Literature DB >> 27236198

Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx.

Brian J McMorran1, Francis E McCarthy1, Elizabeth M Gibbs2, Mabel Pang1, Jamie L Marshall3, Alison V Nairn4, Kelley W Moremen4, Rachelle H Crosbie-Watson2, Linda G Baum5.   

Abstract

The neuromuscular junction (NMJ) is enriched with glycoproteins modified with N-acetylgalactosamine (GalNAc) residues, and four nominally GalNAc-specific plant lectins have historically been used to identify the NMJ and the utrophin-glycoprotein complex. However, little is known about the specific glycan epitopes on skeletal muscle that are bound by these lectins, the glycoproteins that bear these epitopes or how creation of these glycan epitopes is regulated. Here, we profile changes in cell surface glycosylation during muscle cell differentiation and identify distinct differences in the binding preferences of GalNAc-specific lectins, Wisteria floribunda agglutinin (WFA), Vicia villosa agglutinin (VVA), soybean agglutinin (SBA) and Dolichos biflorus agglutinin (DBA). While we find that all four GalNAc binding lectins specifically label the NMJ, each of the four lectins binds distinct sets of muscle glycoproteins; furthermore, none of the major adhesion complexes are required for binding of any of the four GalNAc-specific lectins. Analysis of glycosylation-related transcripts identified target glycosyltransferases and glycosidases that could potentially create GalNAc-containing epitopes; reducing expression of these transcripts by siRNA highlighted differences in lectin binding specificities. In addition, we found that complex N-glycans are required for binding of WFA and SBA to murine C2C12 myotubes and for WFA binding to wild-type skeletal muscle, but not for binding of VVA or DBA. These results demonstrate that muscle cell surface glycosylation is finely regulated during muscle differentiation in a domain- and acceptor-substrate-specific manner, suggesting that temporal- and site-specific glycosylation are important for skeletal muscle cell function.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GalNAc; Wisteria floribunda agglutinin; muscle glycosylation; neuromuscular junction; utrophin–glycoprotein complex

Mesh:

Substances:

Year:  2016        PMID: 27236198      PMCID: PMC5241718          DOI: 10.1093/glycob/cww061

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  52 in total

1.  Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice.

Authors:  Alison R Amenta; Atilgan Yilmaz; Sasha Bogdanovich; Beth A McKechnie; Mehrdad Abedi; Tejvir S Khurana; Justin R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Binding profile of Artocarpus integrifolia agglutinin (Jacalin).

Authors:  Albert M Wu; June H Wu; Li-Hua Lin; Shin-Hua Lin; Jia-Hau Liu
Journal:  Life Sci       Date:  2003-04-04       Impact factor: 5.037

3.  Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.

Authors:  Ana Magalhães; Ricardo Marcos-Pinto; Alison V Nairn; Mitche Dela Rosa; Rui M Ferreira; Susana Junqueira-Neto; Daniela Freitas; Joana Gomes; Patrícia Oliveira; Marta R Santos; Nuno T Marcos; Wen Xiaogang; Céu Figueiredo; Carla Oliveira; Mário Dinis-Ribeiro; Fátima Carneiro; Kelley W Moremen; Leonor David; Celso A Reis
Journal:  Biochim Biophys Acta       Date:  2015-07-02

4.  Strong affinity of Maackia amurensis hemagglutinin (MAH) for sialic acid-containing Ser/Thr-linked carbohydrate chains of N-terminal octapeptides from human glycophorin A.

Authors:  Y Konami; K Yamamoto; T Osawa; T Irimura
Journal:  FEBS Lett       Date:  1994-04-11       Impact factor: 4.124

5.  Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Pam M Van Ry; Ryan D Wuebbles; Megan Key; Dean J Burkin
Journal:  Mol Ther       Date:  2015-06-08       Impact factor: 11.454

6.  Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.

Authors:  Holly H Nguyen; Vianney Jayasinha; Bing Xia; Kwame Hoyte; Paul T Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  Decreased surface sialic acid content is a sensitive indicator of muscle damage.

Authors:  Yuko Iwata; Osamu Suzuki; Shigeo Wakabayashi
Journal:  Muscle Nerve       Date:  2013-02-04       Impact factor: 3.217

8.  Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle.

Authors:  A Clerk; G E Morris; V Dubowitz; K E Davies; C A Sewry
Journal:  Histochem J       Date:  1993-08

9.  Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer.

Authors:  Karen L Abbott; Alison V Nairn; Erica M Hall; Marc B Horton; John F McDonald; Kelley W Moremen; Daniela M Dinulescu; Michael Pierce
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

10.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more
  5 in total

Review 1.  Extracellular heparan sulfate proteoglycans and glycan-binding lectins orchestrate trans-synaptic signaling.

Authors:  Emma Rushton; Danielle L Kopke; Kendal Broadie
Journal:  J Cell Sci       Date:  2020-08-11       Impact factor: 5.285

2.  The Role of Glycosylation in Inflammatory Diseases.

Authors:  Inês Alves; Manuel M Vicente; Ana M Dias; Joana Gaifem; Cláudia Rodrigues; Ana Campar; Salomé S Pinho
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Lectin-binding characterizes the healthy human skeletal muscle glycophenotype and identifies disease-specific changes in dystrophic muscle.

Authors:  Brian J McMorran; M Carrie Miceli; Linda G Baum
Journal:  Glycobiology       Date:  2017-12-01       Impact factor: 4.313

Review 4.  Glycans as Key Checkpoints of T Cell Activity and Function.

Authors:  Márcia S Pereira; Inês Alves; Manuel Vicente; Ana Campar; Mariana C Silva; Nuno A Padrão; Vanda Pinto; Ângela Fernandes; Ana M Dias; Salomé S Pinho
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

5.  Accumulation of α-2,6-sialyoglycoproteins in the Muscle Sarcoplasm Due to Trichinella Sp. Invasion.

Authors:  Rositsa Milcheva; Pavol Janega; Peter Celec; Svetlozara Petkova; Zuzana Hurniková; Barbora Izrael-Vlková; Katerina Todorova; Pavel Babál
Journal:  Open Life Sci       Date:  2019-12-18       Impact factor: 0.938

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.